Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Buy
11,378
+2,560
+29% +$226K ﹤0.01% 742
2025
Q4
$575K Buy
8,818
+987
+13% +$78.7K ﹤0.01% 1061
2025
Q3
$643K Sell
7,831
-1,734
-18% -$125K ﹤0.01% 978
2025
Q2
$630K Sell
9,565
-2,383
-20% -$148K ﹤0.01% 989
2025
Q1
$784K Sell
11,948
-2,752
-19% -$186K ﹤0.01% 890
2024
Q4
$1.13M Buy
14,700
+3,378
+30% +$292K ﹤0.01% 862
2024
Q3
$946K Buy
11,322
+2,881
+34% +$192K ﹤0.01% 833
2024
Q2
$466K Sell
8,441
-2,149
-20% -$117K ﹤0.01% 1022
2024
Q1
$737K Buy
10,590
+1,131
+12% +$71.7K ﹤0.01% 888
2023
Q4
$525K Buy
9,459
+1,367
+17% +$61.7K ﹤0.01% 1011
2023
Q3
$290K Buy
8,092
+51
+0.6% +$1.76K ﹤0.01% 1226
2023
Q2
$254K Buy
8,041
+1,521
+23% +$58.1K ﹤0.01% 1383
2023
Q1
$201K Sell
6,520
-911
-12% -$27.6K ﹤0.01% 1448
2022
Q4
$230K Buy
+7,431
New +$170K ﹤0.01% 1396

Other funds holding ACLX

ProShare Advisors's ACLX Position: Q1 2026 in Review

ProShare Advisors increased its Arcellx (ACLX) stake by 29% in Q1 2026, buying an estimated $226K and bringing the position to 11,378 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #742.

ProShare Advisors first reported a position in ACLX in Q4 2022 and has held it in 14 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • ProShare Advisors held 11,378 shares of Arcellx worth $1.31M as of Q1 2026.
  • ProShare Advisors bought 2,560 Arcellx shares in Q1 2026, an estimated $226K.
  • Arcellx made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #742 holding.
  • ProShare Advisors first reported a position in Arcellx in Q4 2022 and has held it in 14 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.